Publication:
Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.

dc.contributor.authorHol, J A
dc.contributor.authorLopez-Yurda, M I
dc.contributor.authorVan Tinteren, H
dc.contributor.authorVan Grotel, M
dc.contributor.authorGodzinski, J
dc.contributor.authorVujanic, G
dc.contributor.authorOldenburger, F
dc.contributor.authorDe Camargo, B
dc.contributor.authorRamírez-Villar, G L
dc.contributor.authorBergeron, C
dc.contributor.authorPritchard-Jones, K
dc.contributor.authorGraf, N
dc.contributor.authorVan den Heuvel-Eibrink, M M
dc.date.accessioned2023-01-25T13:39:26Z
dc.date.available2023-01-25T13:39:26Z
dc.date.issued2019-08-19
dc.description.abstractTo enhance risk stratification for Wilms tumour (WT) in a pre-operative chemotherapy setting, we explored the prognostic significance and optimal age cutoffs in patients treated according to International Society of Paediatric Oncology Renal Tumour Study Group (SIOP-RTSG) protocols. Patients(6 months-18 years) with unilateral WT were selected from prospective SIOP 93-01 and 2001 studies(1993-2016). Martingale residual analysis was used to explore optimal age cutoffs. Outcome according to age was analyzed by uni- and multivariable analysis, adjusted for sex, biopsy(yes/no), stage, histology and tumour volume at surgery. 5631 patients were included; median age was 3.4 years(IQR: 2-5.1). Estimated 5-year event-free survival (EFS) and overall survival (OS) were 85%(95%CI 83.5-85.5) and 93%(95%CI 92.0-93.4). Martingale residual plots detected no optimal age cutoffs. Multivariable analysis showed lower EFS with increasing age(linear trend P Although optimal age cutoffs could not be identified, we demonstrated the prognostic significance of age as well as previously described cutoffs for EFS (2 and 4 years) and OS (4 years) in children with WT treated with pre-operative chemotherapy. These findings encourage the consideration of age in the design of future SIOP-RTSG protocols.
dc.identifier.doi10.1371/journal.pone.0221373
dc.identifier.essn1932-6203
dc.identifier.pmcPMC6699693
dc.identifier.pmid31425556
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699693/pdf
dc.identifier.unpaywallURLhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0221373&type=printable
dc.identifier.urihttp://hdl.handle.net/10668/14409
dc.issue.number8
dc.journal.titlePloS one
dc.journal.titleabbreviationPLoS One
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.page.numbere0221373
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshAdolescent
dc.subject.meshAge Factors
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshChemotherapy, Adjuvant
dc.subject.meshChild
dc.subject.meshChild, Preschool
dc.subject.meshDisease-Free Survival
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInfant
dc.subject.meshKidney
dc.subject.meshKidney Neoplasms
dc.subject.meshMale
dc.subject.meshNeoplasm Staging
dc.subject.meshNephrectomy
dc.subject.meshPatient Selection
dc.subject.meshPrognosis
dc.subject.meshProspective Studies
dc.subject.meshRisk Assessment
dc.subject.meshRisk Factors
dc.subject.meshTumor Burden
dc.subject.meshWilms Tumor
dc.titlePrognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number14
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6699693.pdf
Size:
1.41 MB
Format:
Adobe Portable Document Format